Advertisement

Neuropsychiatry for the Twenty-First Century

  • Andrea E. Cavanna
Chapter

Abstract

The contemporary era of clinical neuropsychiatry arguably began in the 1980s. The British Neuropsychiatry Association (BNPA) was founded in 1987, and the American Neuropsychiatric Association (ANPA) was established in 1988. The neuropsychiatry of movement disorders and epilepsy has been the traditional clinical and research focus of the Raymond Way Neuropsychiatry Unit (based in London) and the Michael Trimble Neuropsychiatry Research Group (MTNRG, based in Birmingham). The MTNRG was established in 2009 to fulfil the double aim of expressing gratitude to Michael Trimble’s generous guidance to junior clinical researches and ensuring continuity to its scientific and cultural legacy in neuropsychiatry. The first 10 successful years of the MTNRG are but one example of the countless continuing legacies of the neuropsychiatry clinical scientist model represented in its quintessence by Michael Trimble. Illustrative examples of international, national, and local neuropsychiatric institutions provide an overview of research activity in clinical neuropsychiatry in the new millennium.

Keywords

Behavioural neurology Epilepsy Michael Trimble Movement disorders Neuropsychiatry 

MTNRG Publications (2009–2018)

Articles

  1. Agrawal N, Rickards H. Detection and treatment of depression in neurological disorders. J Neurol Neurosurg Psychiatry. 2011;82(8):828–9.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Agrawal N, Bhattacharya R, Rickards H. Provision of neuropsychiatry services: variability and unmet need. BJPsych Bull. 2015;39(6):297–301.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Akintomide GS, Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat. 2011;7:507–18.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN, UKMND-LiCALS. Protocol for a double-blind randomized placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC Neurol. 2011;11:111.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Aldred M, Cavanna AE. Tourette syndrome and socioeconomic status. Neurol Sci. 2015;36(9):1643–9.PubMedCrossRefGoogle Scholar
  6. Ali F, Rickards H, Bagary M, Greenhill L, McCorry D, Cavanna AE. Ictal consciousness in epilepsy and nonepileptic attack disorder. Epilepsy Behav. 2010;19(3):522–5.PubMedCrossRefGoogle Scholar
  7. Ali F, Rickards H, Cavanna AE. The assessment of consciousness during partial seizures. Epilepsy Behav. 2012;23(2):98–102.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Altin JA, Daley SR, Howitt J, Rickards HJ, Batkin AK, Horikawa K, Prasad SJ, Nelms KA, Kumar S, Wu LC, Tan SS, Cook MC, Goodnow CC. Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+ T cells. Proc Natl Acad Sci U S A. 2014;111(6):2067–74.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Alvarez-Silva S, Alvarez-Rodriguez J, Cavanna AE. Epileptic aura and qualitative alterations of consciousness in focal seizures: a neuropsychiatric approach. Epilepsy Behav. 2012;23(4):512–3.PubMedCrossRefGoogle Scholar
  10. Amlerova J, Cavanna AE, Bradac O, Javurkova A, Marusic P. Hyperfamiliarity in patients with temporal lobe epilepsy. Epilepsy Behav. 2012;24(3):332–5.PubMedCrossRefGoogle Scholar
  11. Amlerova J, Cavanna AE, Bradac O, Javurkova A, Raudenska J, Marusic P. Emotion recognition and social cognition in temporal lobe epilepsy and the effect of epilepsy surgery. Epilepsy Behav. 2014;36:86–9.PubMedCrossRefGoogle Scholar
  12. Arambepola NM, Rickards H, Cavanna AE. The evolving discipline and services of neuropsychiatry in the United Kingdom. Acta Neuropsychiatr. 2012;24(4):191–8.PubMedCrossRefGoogle Scholar
  13. Aziz NA, Jurgens CK, Landwehrmeyer GB, EHDN Registry Study Group, van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology. 2009;73(16):1280–5.PubMedCrossRefGoogle Scholar
  14. Bagshaw AP, Cavanna AE. Brain mechanisms of altered consciousness in focal seizures. Behav Neurol. 2011;24(1):35–41.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Bagshaw AP, Cavanna AE. Resting state networks in paroxysmal disorders of consciousness. Epilepsy Behav. 2013;26(3):290–4.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Bagshaw AP, Rollings DT, Khalsa S, Cavanna AE. Multimodal neuroimaging investigations of alterations to consciousness: the relationship between absence epilepsy and sleep. Epilepsy Behav. 2014;30:33–7.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Balarajah S, Cavanna AE. The pathophysiology of impulse control disorders in Parkinson disease. Behav Neurol. 2013;26(4):237–44.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Balottin L, Selvini C, Luoni C, Mannarini S, Chiappedi M, Seri S, Termine C, Cavanna AE. personality profile of male adolescents with Tourette syndrome: a controlled study. J Child Neurol. 2016;31(3):294–9.PubMedCrossRefGoogle Scholar
  19. Bangar S, Shastri A, El-Sayeh H, Cavanna AE. Women with epilepsy: clinically relevant issues. Funct Neurol. 2016;31(3):127–34.PubMedPubMedCentralGoogle Scholar
  20. Barns Neurauter MP, Rickards H, Cavanna AE. The prevalence and clinical characteristics of pathological gambling in Parkinson’s disease: an evidence-based review. Funct Neurol. 2010;25(1):9–13.PubMedGoogle Scholar
  21. Bhattacharya R, Rickards H, Agrawal N. Commissioning neuropsychiatry services: barriers and lessons. BJPsych Bull. 2015;39(6):291–6.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Bonner-Jackson A, Long JD, Westervelt H, Tremont G, Aylward E, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Cognitive reserve and brain reserve in prodromal Huntington’s disease. J Int Neuropsychol Soc. 2013;19(7):739–50.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Carlozzi NE, Stout JC, Mills JA, Duff K, Beglinger LJ, Aylward EH, Whitlock KB, Solomon AC, Queller S, Langbehn DR, Johnson SA, Paulsen JS, Predict-Hd Investigators Of The Huntington Study Group. Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. Clin Neuropsychol. 2011;25(5):757–77.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Carson AJ, Brown R, David AS, Duncan R, Edwards MJ, Goldstein LH, Grunewald R, Howlett S, Kanaan R, Mellers J, Nicholson TR, Reuber M, Schrag AE, Stone J, Voon V, UK-FNS. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry. 2012;83(8):842–50.CrossRefPubMedGoogle Scholar
  25. Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry. 2011;20(4):155–71.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Cauda F, Geminiani G, D’Agata F, Sacco K, Duca S, Bagshaw AP, Cavanna AE. Functional connectivity of the posteromedial cortex. PLoS One. 2010;5(9):e13107.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Cauda F, Cavanna AE, D’Agata F, Sacco K, Duca S, Geminiani GC. Functional connectivity and coactivation of the nucleus accumbens: a combined functional connectivity and structure-based meta-analysis. J Cogn Neurosci. 2011;23(10):2864–77.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Cavallo M, Cavanna AE, Harciarek M, Johnston H, Ostacoli L, Angilletta C. “Keep up the good work”! A case study of the effects of a specific cognitive training in Alzheimer’s disease. Neurocase. 2013;19(6):542–52.PubMedCrossRefGoogle Scholar
  29. Cavanna AE. Epilepsy and disorders of consciousness. Behav Neurol. 2011;24(1):1.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Cavanna AE. Behavioural and cognitive dysfunction across basal ganglia disorders. J Neurol Neurosurg Psychiatry. 2012;83(10):950–1.PubMedCrossRefGoogle Scholar
  31. Cavanna AE. Researching Tourette syndrome in Europe. Behav Neurol. 2013;27(1):1–2.PubMedCrossRefGoogle Scholar
  32. Cavanna AE. The behavioural neurology of basal ganglia disorders. Behav Neurol. 2013;26(4):217–8.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Cavanna AE. Epilepsy as a pathology of consciousness. Epilepsy Behav. 2014;30:1.PubMedCrossRefGoogle Scholar
  34. Cavanna AE. Epilepsy, behavior, and neuropsychiatry. Epilepsy Behav. 2014;40:78.PubMedCrossRefGoogle Scholar
  35. Cavanna AE. What is misophonia and how can we treat it? Expert Rev Neurother. 2014;14(4):357–9.PubMedCrossRefGoogle Scholar
  36. Cavanna AE. Neuroimaging and neurophysiology in psychiatry. Br J Psychiatry. 2017;210(4):302.CrossRefGoogle Scholar
  37. Cavanna AE. Neuropsychiatric symptoms of epilepsy. Br J Psychiatry. 2017;210(5):371.CrossRefGoogle Scholar
  38. Cavanna AE. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder. CNS Spectr. 2018;21:1–6.Google Scholar
  39. Cavanna AE, Ali F. Epilepsy: the quintessential pathology of consciousness. Behav Neurol. 2011;24(1):3–10.PubMedPubMedCentralCrossRefGoogle Scholar
  40. Cavanna A, Cavanna AE. Christian VII of Denmark and Tourette syndrome: fact or fiction? Neurol Sci. 2014;35(10):1611–2.PubMedCrossRefGoogle Scholar
  41. Cavanna AE, Martino D. How many Gilles de la Tourette syndromes? Eur J Neurol. 2014;21(5):685–6.PubMedCrossRefGoogle Scholar
  42. Cavanna AE, Monaco F. Brain mechanisms of altered conscious states during epileptic seizures. Nat Rev Neurol. 2009;5(5):267–76.CrossRefPubMedGoogle Scholar
  43. Cavanna AE, Nani A. Antiepileptic drugs and Tourette syndrome. Int Rev Neurobiol. 2013;112:373–89.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Cavanna AE, Nani A. Tourette syndrome and consciousness of action. Tremor Other Hyperkinet Mov (N Y). 2013;23:3.Google Scholar
  45. Cavanna AE, Rickards H. The psychopathological spectrum of Gilles de la Tourette syndrome. Neurosci Biobehav Rev. 2013;37(6):1008–15.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Cavanna AE, Seri S. Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities. Epilepsy Behav. 2013;29(2):281–4.PubMedCrossRefGoogle Scholar
  47. Cavanna AE, Seri S. Tourette’s syndrome. BMJ. 2013;347:f4964.PubMedCrossRefGoogle Scholar
  48. Cavanna AE, Seri S. Misophonia: current perspectives. Neuropsychiatr Dis Treat. 2015;11:2117–23.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Cavanna AE, Seri S. Neurophysiological investigations for the diagnosis of non-epileptic attack disorder in neuropsychiatry services: from safety standards to improved effectiveness. Acta Neuropsychiatr. 2016;28(4):185–94.PubMedPubMedCentralCrossRefGoogle Scholar
  50. Cavanna AE, Termine C. Tourette syndrome. Adv Exp Med Biol. 2012;724:375–83.PubMedCrossRefPubMedCentralGoogle Scholar
  51. Cavanna AE, Williams AC. Neuropsychiatric symptoms in an early description of pellagra. J Neuropsychiatry Clin Neurosci. 2010;22(4):451:E39.CrossRefGoogle Scholar
  52. Cavanna AE, Bagshaw AP, McCorry D. The neural correlates of altered consciousness during epileptic seizures. Discov Med. 2009;8(40):31–6.PubMedPubMedCentralGoogle Scholar
  53. Cavanna AE, Bertero L, Cavanna S, Servo S, Strigaro G, Monaco F. Persistent akinetic mutism after bilateral paramedian thalamic infarction. J Neuropsychiatry Clin Neurosci. 2009;21(3):351.PubMedCrossRefPubMedCentralGoogle Scholar
  54. Cavanna AE, Cavanna S, Bertero L, Robertson MM. Depression in women with epilepsy: clinical and neurobiological aspects. Funct Neurol. 2009;24(2):83–7.PubMedPubMedCentralGoogle Scholar
  55. Cavanna AE, Eddy C, Rickards HE. Cognitive functioning in Tourette syndrome. Discov Med. 2009;8(43):191–5.PubMedPubMedCentralGoogle Scholar
  56. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2009;21(1):13–23.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Cavanna AE, Ali F, Leckman JF, Robertson MM. Pathological laughter in Gilles de la Tourette syndrome: an unusual phonic tic. Mov Disord. 2010;25(13):2233–9.PubMedCrossRefPubMedCentralGoogle Scholar
  58. Cavanna AE, Ali F, Rickards HE, McCorry D. Behavioral and cognitive effects of anti-epileptic drugs. Discov Med. 2010;9(45):138–44.PubMedPubMedCentralGoogle Scholar
  59. Cavanna AE, Cavanna S, Cavanna A. Epileptic seizures and spirit possession in Haitian culture: report of four cases and review of the literature. Epilepsy Behav. 2010;19(1):89–91.PubMedCrossRefPubMedCentralGoogle Scholar
  60. Cavanna AE, Cavanna SL, Servo S, Monaco F. The neural correlates of impaired consciousness in coma and unresponsive states. Discov Med. 2010;9(48):431–8.PubMedGoogle Scholar
  61. Cavanna AE, Pattumelli MG, Quarto T, Ali F, Rickards H. The “imprisoned illness:” motor tic disorder in Rainer Maria Rilke’s Notebooks of Malte Laurids Brigge. Mov Disord. 2010;25(12):1980–2.PubMedCrossRefGoogle Scholar
  62. Cavanna AE, Stecco A, Rickards H, Servo S, Terazzi E, Peterson B, Robertson MM, Carriero A, Monaco F. Corpus callosum abnormalities in Tourette syndrome: an MRI-DTI study of monozygotic twins. J Neurol Neurosurg Psychiatry. 2010;81(5):533–5.PubMedCrossRefGoogle Scholar
  63. Cavanna AE, Ali F, Rickards H. Paligraphia and written jocularity in Gilles de la Tourette syndrome. Mov Disord. 2011;26(5):930–1.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Cavanna AE, Critchley HD, Orth M, Stern JS, Young MB, Robertson MM. Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients. J Neurol Neurosurg Psychiatry. 2011;82(12):1320–3.PubMedCrossRefPubMedCentralGoogle Scholar
  65. Cavanna AE, Eddy CM, Mitchell R, Pall H, Mitchell I, Zrinzo L, Foltynie T, Jahanshahi M, Limousin P, Hariz MI, Rickards H. An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg. 2011;25(1):38–44.CrossRefPubMedGoogle Scholar
  66. Cavanna AE, Rickards H, Ali F. What makes a simple partial seizure complex? Epilepsy Behav. 2011;22(4):651–8.CrossRefPubMedGoogle Scholar
  67. Cavanna AE, Shah S, Eddy CM, Williams A, Rickards H. Consciousness: a neurological perspective. Behav Neurol. 2011;24(1):107–16.PubMedPubMedCentralCrossRefGoogle Scholar
  68. Cavanna AE, David K, Orth M, Robertson MM. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome. Eur J Paediatr Neurol. 2012;16(6):605–12.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Cavanna AE, Rickards H, Worrall R, Hoekstra PJ, Plessen KJ, Roessner V. From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome. Eur J Paediatr Neurol. 2012;16(3):310–1.PubMedCrossRefPubMedCentralGoogle Scholar
  70. Cavanna AE, Selvini C, Termine C, Balottin U, Eddy CM. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome. Clin Neuropharmacol. 2012;35(6):269–72.PubMedCrossRefGoogle Scholar
  71. Cavanna AE, Selvini C, Termine C, Luoni C, Eddy CM, Rickards H. Tolerability profile of aripiprazole in patients with Tourette syndrome. J Psychopharmacol. 2012;26(6):891–5.PubMedCrossRefGoogle Scholar
  72. Cavanna AE, David K, Bandera V, Termine C, Balottin U, Schrag A, Selai C. Health-related quality of life in Gilles de la Tourette syndrome: a decade of research. Behav Neurol. 2013;27(1):83–93.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Cavanna AE, Kavanagh C, Robertson MM. The future of research in Tourette syndrome. Behav Neurol. 2013;27(1):139–42.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Cavanna AE, Luoni C, Selvini C, Blangiardo R, Eddy CM, Silvestri PR, Calì PV, Seri S, Balottin U, Cardona F, Rizzo R, Termine C. The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version. Behav Neurol. 2013;27(1):95–103.PubMedPubMedCentralCrossRefGoogle Scholar
  75. Cavanna AE, Luoni C, Selvini C, Blangiardo R, Eddy CM, Silvestri PR, Calì PV, Gagliardi E, Balottin U, Cardona F, Rizzo R, Termine C. Disease-specific quality of life in young patients with Tourette syndrome. Pediatr Neurol. 2013;48(2):111–4.PubMedCrossRefGoogle Scholar
  76. Cavanna AE, Luoni C, Selvini C, Blangiardo R, Eddy CM, Silvestri PR, Cali’ PV, Gagliardi E, Balottin U, Cardona F, Rizzo R, Termine C. Parent and self-report health-related quality of life measures in young patients with Tourette syndrome. J Child Neurol. 2013;28(10):1305–8.PubMedPubMedCentralCrossRefGoogle Scholar
  77. Cavanna AE, Mitchell JW, Williams AC. The neuropsychiatry of pellagra in early American studies. J Neuropsychiatry Clin Neurosci. 2013;25(4):E08.PubMedCrossRefGoogle Scholar
  78. Cavanna AE, Nani A, Williams AC. Parkinsonian features in a case of pellagra: a historical report. J Parkinsons Dis. 2013;3(4):539–45.PubMedGoogle Scholar
  79. Cavanna AE, Nani A, Trimble MR. Emperor Claudius’ neuropsychiatric presentation: from tics to behavioral symptoms. J Neuropsychiatry Clin Neurosci. 2014;26(3):E36–7.PubMedCrossRefGoogle Scholar
  80. Cavanna AE, Black KJ, Hallett M, Voon V. Neurobiology of the premonitory urge in Tourette’s syndrome: pathophysiology and treatment implications. J Neuropsychiatry Clin Neurosci. 2017;29(2):95–104.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Conwill M, Oakley L, Evans K, Cavanna AE. CBT-based group therapy intervention for nonepileptic attacks and other functional neurological symptoms: a pilot study. Epilepsy Behav. 2014;34:68–72.PubMedCrossRefGoogle Scholar
  82. Cox JH, Cavanna AE. Irritability symptoms in Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2015;27(1):42–7.CrossRefPubMedGoogle Scholar
  83. Cox JH, Seri S, Cavanna AE. Clinical guidelines on long-term pharmacotherapy for bipolar disorder in children and adolescents. J Clin Med. 2014;3(1):135–43.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Cox JH, Seri S, Cavanna AE. Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures. Neuropsychiatr Dis Treat. 2014;10:2191–200.PubMedPubMedCentralGoogle Scholar
  85. Cox JH, Seri S, Cavanna AE. Zonisamide as a treatment for partial epileptic seizures: a systematic review. Adv Ther. 2014;31(3):276–88.PubMedCrossRefGoogle Scholar
  86. Cox JH, Seri S, Cavanna AE. Sensory aspects of Tourette syndrome. Neurosci Biobehav Rev. 2018;88:170–6.PubMedCrossRefGoogle Scholar
  87. Crossley E, Cavanna AE. Sensory phenomena: clinical correlates and impact on quality of life in adult patients with Tourette syndrome. Psychiatry Res. 2013;209(3):705–10.PubMedCrossRefGoogle Scholar
  88. Crossley E, Seri S, Stern JS, Robertson MM, Cavanna AE. Premonitory urges for tics in adult patients with Tourette syndrome. Brain Dev. 2014;36(1):45–50.PubMedCrossRefGoogle Scholar
  89. Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C, European HD Network. Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology. 2016;87(6):571–8.PubMedGoogle Scholar
  90. Cuenca J, Glazebrook C, Kendall T, Hedderly T, Heyman I, Jackson G, Murphy T, Rickards H, Robertson M, Stern J, Trayner P, Hollis C. Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study. BMC Psychiatry. 2015;15:46.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Curtis A, Clarke CE, Rickards HE. Cannabinoids for Tourette’s Syndrome. Cochrane Database Syst Rev. 2009;(4):CD006565.Google Scholar
  92. Curtis A, Mitchell I, Patel S, Ives N, Rickards H. A pilot study using nabilone for symptomatic treatment in Huntington’s disease. Mov Disord. 2009;24(15):2254–9.PubMedCrossRefPubMedCentralGoogle Scholar
  93. Dale M, Maltby J, Shimozaki S, Cramp R, Rickards H, REGISTRY Investigators of the European Huntington’s Disease Network. Disease stage, but not sex, predicts depression and psychological distress in Huntington’s disease: a European population study. J Psychosom Res. 2016;80:17–22.PubMedCrossRefPubMedCentralGoogle Scholar
  94. De Souza J, Jones LA, Rickards H. Validation of self-report depression rating scales in Huntington’s disease. Mov Disord. 2010;25(1):91–6.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Demetriades P, Rickards H, Cavanna AE. Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: clinical aspects. Parkinsons Dis. 2011;658415.Google Scholar
  96. Draganski B, Martino D, Cavanna AE, Hutton C, Orth M, Robertson MM, Critchley HD, Frackowiak RS. Multispectral brain morphometry in Tourette syndrome persisting into adulthood. Brain. 2010;133(Pt 12):3661–75.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat. 2011;274736.Google Scholar
  98. Dutta N, Cavanna AE. The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. Funct Neurol. 2013;28(1):7–12.PubMedPubMedCentralGoogle Scholar
  99. Eapen V, Cavanna AE, Robertson MM. Comorbidities, social impact, and quality of life in Tourette syndrome. Front Psychiatry. 2016;7:97.PubMedPubMedCentralCrossRefGoogle Scholar
  100. Eddy CM, Cavanna AE. Altered social cognition in Tourette syndrome: nature and implications. Behav Neurol. 2013;27(1):15–22.PubMedPubMedCentralCrossRefGoogle Scholar
  101. Eddy CM, Cavanna AE. ‘It’s a curse!’: coprolalia in Tourette syndrome. Eur J Neurol. 2013;20(11):1467–70.PubMedGoogle Scholar
  102. Eddy CM, Cavanna AE. On being your own worst enemy: an investigation of socially inappropriate symptoms in Tourette syndrome. J Psychiatr Res. 2013;47(9):1259–63.PubMedCrossRefGoogle Scholar
  103. Eddy CM, Cavanna AE. Do patients with Tourette syndrome jump to conclusions? J Neuropsychiatry Clin Neurosci. 2014;26(4):396–9.PubMedCrossRefGoogle Scholar
  104. Eddy CM, Cavanna AE. Premonitory urges in adults with complicated and uncomplicated Tourette syndrome. Behav Modif. 2014;38(2):264–75.PubMedCrossRefGoogle Scholar
  105. Eddy CM, Cavanna AE. Video-electroencephalography investigation of ictal alterations of consciousness in epilepsy and nonepileptic attack disorder: practical considerations. Epilepsy Behav. 2014;30:24–7.CrossRefPubMedGoogle Scholar
  106. Eddy CM, Cavanna AE. Triangles, tricks and tics: hyper-mentalizing in response to animated shapes in Tourette syndrome. Cortex. 2015;71:68–75.PubMedCrossRefGoogle Scholar
  107. Eddy CM, Cavanna AE. Set-shifting deficits: a possible neurocognitive endophenotype for Tourette syndrome without ADHD. J Atten Disord. 2017;21(10):824–34.PubMedCrossRefPubMedCentralGoogle Scholar
  108. Eddy CM, Rickards HE. Cognitive deficits predict poorer functional capacity in Huntington’s disease: but what is being measured? Neuropsychology. 2015;29(2):268–73.PubMedCrossRefPubMedCentralGoogle Scholar
  109. Eddy CM, Rickards HE. Interaction without intent: the shape of the social world in Huntington’s disease. Soc Cogn Affect Neurosci. 2015;10(9):1228–35.PubMedPubMedCentralCrossRefGoogle Scholar
  110. Eddy CM, Rickards HE. Theory of mind can be impaired prior to motor onset in Huntington’s disease. Neuropsychology. 2015;29(5):792–8.PubMedCrossRefPubMedCentralGoogle Scholar
  111. Eddy CM, Rizzo R, Cavanna AE. Neuropsychological aspects of Tourette syndrome: a review. J Psychosom Res. 2009;67(6):503–13.PubMedCrossRefPubMedCentralGoogle Scholar
  112. Eddy CM, Mitchell IJ, Beck SR, Cavanna AE, Rickards HE. Altered attribution of intention in Tourette’s syndrome. J Neuropsychiatry Clin Neurosci. 2010;22(3):348–51.PubMedCrossRefPubMedCentralGoogle Scholar
  113. Eddy CM, Mitchell IJ, Beck SR, Cavanna AE, Rickards HE. Impaired comprehension of nonliteral language in Tourette syndrome. Cogn Behav Neurol. 2010;23(3):178–84.PubMedCrossRefPubMedCentralGoogle Scholar
  114. Eddy CM, Rizzo R, Gulisano M, Calì P, Robertson MM, Cavanna AE. Quality of life in young people with treatment-responsive epilepsy: a controlled study. Epilepsy Behav. 2010;19(4):623–6.PubMedCrossRefPubMedCentralGoogle Scholar
  115. Eddy CM, Cavanna AE, Gulisano M, Agodi A, Barchitta M, Calì P, Robertson MM, Rizzo R. Clinical correlates of quality of life in Tourette syndrome. Mov Disord. 2011;26(4):735–8.PubMedCrossRefPubMedCentralGoogle Scholar
  116. Eddy CM, Mitchell IJ, Beck SR, Cavanna AE, Rickards H. Social reasoning in Tourette syndrome. Cogn Neuropsychiatry. 2011;16(4):326–47.PubMedCrossRefPubMedCentralGoogle Scholar
  117. Eddy CM, Mitchell IJ, Beck SR, Cavanna AE, Rickards HE. Altered subjective fear responses in Huntington’s disease. Parkinsonism Relat Disord. 2011;17(5):386–9.PubMedCrossRefPubMedCentralGoogle Scholar
  118. Eddy CM, Rickards HE, Cavanna AE. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord. 2011;4(6):385–407.PubMedPubMedCentralCrossRefGoogle Scholar
  119. Eddy CM, Rickards HE, Cavanna AE. Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Disord. 2011;4(1):25–45.PubMedPubMedCentralCrossRefGoogle Scholar
  120. Eddy CM, Rizzo R, Gulisano M, Agodi A, Barchitta M, Calì P, Robertson MM, Cavanna AE. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol. 2011;258(2):291–301.PubMedCrossRefPubMedCentralGoogle Scholar
  121. Eddy CM, Cavanna AE, Gulisano M, Calì P, Robertson MM, Rizzo R. The effects of comorbid obsessive-compulsive disorder and attention-deficit hyperactivity disorder on quality of life in Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2012;24(4):458–62.PubMedCrossRefGoogle Scholar
  122. Eddy CM, Rickards HE, Cavanna AE. Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol. 2012;32(3):362–75.PubMedCrossRefGoogle Scholar
  123. Eddy CM, Rickards HE, Cavanna AE. Executive functions in uncomplicated Tourette syndrome. Psychiatry Res. 2012;200(1):46–8.PubMedCrossRefGoogle Scholar
  124. Eddy CM, Sira Mahalingappa S, Rickards HE. Is Huntington’s disease associated with deficits in theory of mind? Acta Neurol Scand. 2012;126(6):376–83.PubMedCrossRefGoogle Scholar
  125. Eddy CM, Rickards HE, Critchley HD, Cavanna AE. A controlled study of personality and affect in Tourette syndrome. Compr Psychiatry. 2013;54(2):105–10.PubMedCrossRefGoogle Scholar
  126. Eddy CM, Rickards HE, Cavanna AE. Physiological awareness is negatively related to inhibitory functioning in Tourette syndrome. Behav Modif. 2014;38(2):319–35.PubMedCrossRefGoogle Scholar
  127. Eddy CM, Sira Mahalingappa S, Rickards HE. Putting things into perspective: the nature and impact of theory of mind impairment in Huntington’s disease. Eur Arch Psychiatry Clin Neurosci. 2014;264(8):697–705.PubMedCrossRefGoogle Scholar
  128. Eddy CM, Macerollo A, Martino D, Cavanna AE. Interpersonal reactivity differences in Tourette syndrome. Psychiatry Res. 2015;228(3):932–5.PubMedCrossRefGoogle Scholar
  129. Eddy CM, Cavanna AE, Rickards HE, Hansen PC. Temporo-parietal dysfunction in Tourette syndrome: Insights from an fMRI study of Theory of Mind. J Psychiatr Res. 2016;81:102–11.PubMedCrossRefGoogle Scholar
  130. Eddy CM, Parkinson EG, Rickards HE. Changes in mental state and behaviour in Huntington’s disease. Lancet Psychiatry. 2016;3(11):1079–86.CrossRefPubMedGoogle Scholar
  131. Eddy CM, Cavanna AE, Hansen PC. Empathy and aversion: the neural signature of mentalizing in Tourette syndrome. Psychol Med. 2017;47(3):507–17.PubMedCrossRefGoogle Scholar
  132. Eddy CM, Parkinson EG, Rickards HE. Misdiagnosis of Huntington’s disease—authors’ reply. Lancet Psychiatry. 2017;4(1):21.PubMedCrossRefPubMedCentralGoogle Scholar
  133. Eddy CM, Shapiro K, Clouter A, Hansen PC, Rickards HE. Transcranial direct current stimulation can enhance working memory in Huntington’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2017;77:75–82.PubMedCrossRefPubMedCentralGoogle Scholar
  134. Eddy CM, Rickards HE, Hansen PC. Through your eyes or mine? The neural correlates of mental state recognition in Huntington’s disease. Hum Brain Mapp. 2018;39(3):1354–66.PubMedCrossRefPubMedCentralGoogle Scholar
  135. Evans J, Seri S, Cavanna AE. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review. Eur Child Adolesc Psychiatry. 2016;25(9):939–48.PubMedPubMedCentralCrossRefGoogle Scholar
  136. Francis A, Fink M, Appiani F, Bertelsen A, Bolwig TG, Bräunig P, Caroff SN, Carroll BT, Cavanna AE, Cohen D, Cottencin O, Cuesta MJ, Daniels J, Dhossche D, Fricchione GL, Gazdag G, Ghaziuddin N, Healy D, Klein D, Krüger S, Lee JW, Mann SC, Mazurek M, McCall WV, McDaniel WW, Northoff G, Peralta V, Petrides G, Rosebush P, Rummans TA, Shorter E, Suzuki K, Thomas P, Vaiva G, Wachtel L. Catatonia in diagnostic and statistical manual of mental disorders, fifth edition. J ECT. 2010;26(4):246–7.PubMedPubMedCentralCrossRefGoogle Scholar
  137. Frank M, Cavanna AE. Behavioural treatments for Tourette syndrome: an evidence-based review. Behav Neurol. 2013;27(1):105–17.PubMedPubMedCentralCrossRefGoogle Scholar
  138. Frank MC, Piedad J, Rickards H, Cavanna AE. The role of impulse control disorders in Tourette syndrome: an exploratory study. J Neurol Sci. 2011;310(1-2):276–8.PubMedCrossRefPubMedCentralGoogle Scholar
  139. Ganos C, Erro R, Cavanna AE, Bhatia KP. Functional tics and echophenomena. Parkinsonism Relat Disord. 2014;20(12):1440–1.PubMedCrossRefPubMedCentralGoogle Scholar
  140. Gulisano M, Calì PV, Cavanna AE, Eddy C, Rickards H, Rizzo R. Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci. 2011;32(6):1213–7.PubMedCrossRefPubMedCentralGoogle Scholar
  141. Hanoğlu L, Özkara Ç, Yalçiner B, Nani A, Cavanna AE. Epileptic qualia and self-awareness: a third dimension for consciousness. Epilepsy Behav. 2014;30:62–5.PubMedCrossRefPubMedCentralGoogle Scholar
  142. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012;83(6):612–9.PubMedCrossRefPubMedCentralGoogle Scholar
  143. Hassan N, Cavanna AE. The prognosis of Tourette syndrome: implications for clinical practice. Funct Neurol. 2012;27(1):23–7.PubMedPubMedCentralGoogle Scholar
  144. Hassiem F, Cavanna AE. Multiple tics in a patient with Adams-Oliver syndrome. J Neuropsychiatry Clin Neurosci. 2015;27(1):e80.PubMedCrossRefPubMedCentralGoogle Scholar
  145. Hawksley J, Cavanna AE, Nagai Y. The role of the autonomic nervous system in Tourette syndrome. Front Neurosci. 2015;9:117.PubMedPubMedCentralCrossRefGoogle Scholar
  146. Hensman Moss DJ, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S, TRACK-HD investigators, REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ. Identification of genetic variants associated with Huntington’s disease progression: a genome-wide association study. Lancet Neurol. 2017;16(9):701–11.PubMedCrossRefPubMedCentralGoogle Scholar
  147. Hindle Fisher I, Pall HS, Mitchell RD, Kausar J, Cavanna AE. Apathy in patients with Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. CNS Spectr. 2016;21(3):258–64.PubMedCrossRefPubMedCentralGoogle Scholar
  148. Hollis C, Pennant M, Cuenca J, Glazebrook C, Kendall T, Whittington C, Stockton S, Larsson L, Bunton P, Dobson S, Groom M, Hedderly T, Heyman I, Jackson GM, Jackson S, Murphy T, Rickards H, Robertson M, Stern J. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. Health Technol Assess. 2016;20(4):1–450.PubMedPubMedCentralCrossRefGoogle Scholar
  149. Hoppitt T, Calvert M, Pall H, Rickards H, Sackley C. Huntington’s disease. Lancet. 2010;376(9751):1463–4.PubMedCrossRefPubMedCentralGoogle Scholar
  150. HORIZON Investigators of the Huntington Study Group and European Huntington’s Disease Network. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol. 2013;70(1):25–33.CrossRefGoogle Scholar
  151. Hovik KT, Plessen KJ, Cavanna AE, Skogli EW, Andersen PN, Øie M. Cognition, emotion and behavior in children with Tourette’s syndrome and children with ADHD-combined subtype—a two-year follow-up study. PLoS One. 2015;10(12):e0144874.PubMedPubMedCentralCrossRefGoogle Scholar
  152. Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ, REGISTRY investigators of the European Huntington’s Disease Network. Suicidal ideation in a European Huntington’s disease population. J Affect Disord. 2013;151(1):248–58.PubMedCrossRefPubMedCentralGoogle Scholar
  153. Jones R, Cavanna AE. The neurobiology and treatment of restless legs syndrome. Behav Neurol. 2013;26(4):283–92.PubMedPubMedCentralCrossRefGoogle Scholar
  154. Jones R, Rickards H, Cavanna AE. Gabapentin enacarbil: pharmacotherapy of restless legs syndrome. J Cent Nerv Syst Dis. 2010;2:45–55.PubMedPubMedCentralCrossRefGoogle Scholar
  155. Jones R, Rickards H, Cavanna AE. The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence. Funct Neurol. 2010;25(4):191–4.PubMedPubMedCentralGoogle Scholar
  156. Kanaan RAA, Duncan R, Goldstein LH, Jankovic J, Cavanna AE. Are psychogenic non-epileptic seizures just another symptom of conversion disorder? J Neurol Neurosurg Psychiatry. 2017;88(5):425–9.CrossRefPubMedGoogle Scholar
  157. Katuwawela I, Cavanna AE. Good response to clonidine in Tourette syndrome associated with chromosomal translocation involving the IMMP2L gene. J Neuropsychiatry Clin Neurosci. 2012;24(1):E17.PubMedCrossRefPubMedCentralGoogle Scholar
  158. Lawley A, Evans S, Manfredonia F, Cavanna AE. The role of outpatient ambulatory electroencephalography in the diagnosis and management of adults with epilepsy or nonepileptic attack disorder: a systematic literature review. Epilepsy Behav. 2015;53:26–30.CrossRefPubMedGoogle Scholar
  159. Lawley A, Manfredonia F, Cavanna AE. Video-ambulatory EEG in a secondary care center: a retrospective evaluation of utility in the diagnosis of epileptic and nonepileptic seizures. Epilepsy Behav. 2016;57(Pt A):137–40.PubMedCrossRefGoogle Scholar
  160. Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB, REGISTRY study of the European Huntington’s Disease Network, Myers RH, HD-MAPS Study Group, MacDonald ME, Gusella JF, COHORT study of the HSG. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78(10):690–5.PubMedPubMedCentralCrossRefGoogle Scholar
  161. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. 8OHdG as a marker for Huntington disease progression. Neurobiol Dis. 2012;46(3):625–34.PubMedPubMedCentralCrossRefGoogle Scholar
  162. López-Sendón JL, Royuela A, Trigo P, Orth M, Lange H, Reilmann R, Keylock J, Rickards H, Piacentini S, Squitieri F, Landwehrmeyer B, Witjes-Ane MN, Jurgens CK, Roos RA, Abraira V, de Yébenes JG, European HD Network. What is the impact of education on Huntington’s disease? Mov Disord. 2011;26(8):1489–95.PubMedCrossRefGoogle Scholar
  163. Macerollo A, Martino D, Cavanna AE, Gulisano M, Hartmann A, Hoekstra PJ, Hedderly T, Debes NM, Muller-Vahl K, Neuner I, Porta M, Rickards H, Rizzo R, Cardona F, Roessner V. Refractoriness to pharmacological treatment for tics: a multicentre European audit. J Neurol Sci. 2016;366:136–8.PubMedCrossRefGoogle Scholar
  164. Maltby J, Dale M, Underwood M, Rickards H, Callaghan J, REGISTRY Investigators of the European Huntington’s Disease Network. Exploring the structural relationship between interviewer and self-rated affective symptoms in Huntington’s disease. J Neuropsychiatry Clin Neurosci. 2016;28(3):236–8.PubMedCrossRefPubMedCentralGoogle Scholar
  165. Manfredonia F, Lawley A, Cavanna AE. Impact of video-ambulatory electroencephalography on the medical management of epilepsy. J Neurol Sci. 2016;365:139–42.PubMedCrossRefGoogle Scholar
  166. Mann JP, Cavanna AE. What does epilepsy tell us about the neural correlates of consciousness? J Neuropsychiatry Clin Neurosci. 2011;23(4):375–83.PubMedPubMedCentralCrossRefGoogle Scholar
  167. Mariam N, Cavanna AE. The most cited works in Tourette syndrome. J Child Neurol. 2012;27(10):1250–9.PubMedCrossRefPubMedCentralGoogle Scholar
  168. Martino D, Cavanna AE. Preface: the metamorphoses of Gilles de la Tourette syndrome. Int Rev Neurobiol. 2013;112:xv–x.PubMedCrossRefPubMedCentralGoogle Scholar
  169. Martino D, Cavanna AE, Robertson MM, Orth M. Prevalence and phenomenology of eye tics in Gilles de la Tourette syndrome. J Neurol. 2012;259(10):2137–40.PubMedCrossRefPubMedCentralGoogle Scholar
  170. Martino D, Madhusudan N, Zis P, Cavanna AE. An introduction to the clinical phenomenology of Tourette syndrome. Int Rev Neurobiol. 2013;112:1–33.CrossRefPubMedGoogle Scholar
  171. Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P, Members of the MDS Committee on Rating Scales Development. Systematic review of severity scales and screening instruments for tics: critique and recommendations. Mov Disord. 2017;32(3):467–73.PubMedPubMedCentralCrossRefGoogle Scholar
  172. McCorry DJ, Cavanna AE. New thoughts on first seizure. Clin Med (Lond). 2010;10(4):395–8.CrossRefGoogle Scholar
  173. McCourt AC, O’Donovan KL, Ekblad E, Sand E, Craufurd D, Rosser A, Sanders D, Stoy N, Rickards H, Wierup N, Bates GP, Björkqvist M, Quarrell O. Characterization of gastric mucosa biopsies reveals alterations in Huntington’s disease. PLoS Curr. 2015;26:7.Google Scholar
  174. McNally G, Rickards H, Horton M, Craufurd D. Exploring the validity of the short version of the problem behaviours assessment (PBA-s) for Huntington’s disease: a Rasch analysis. J Huntingtons Dis. 2015;4(4):347–69.PubMedCrossRefPubMedCentralGoogle Scholar
  175. Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D, REGISTRY Investigators of the European Huntington’s Disease Network, Nguyen HP. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One. 2013;8(7):e68951.PubMedPubMedCentralCrossRefGoogle Scholar
  176. Mitchell JW, Cavanna AE. Handwriting abnormality in Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2013;25(2):E40–1.PubMedCrossRefPubMedCentralGoogle Scholar
  177. Mitchell JW, Cavanna AE. Bilateral shoe deterioration as a result of complex motor tics in Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2014;26(2):E22–3.PubMedCrossRefPubMedCentralGoogle Scholar
  178. Mitchell JW, Ali F, Cavanna AE. Dissociative experiences and quality of life in patients with non-epileptic attack disorder. Epilepsy Behav. 2012;25(3):307–12.CrossRefPubMedGoogle Scholar
  179. Mitchell JW, Seri S, Cavanna AE. Pharmacotherapeutic and non-pharmacological options for refractory and difficult-to-treat seizures. J Cent Nerv Syst Dis. 2012;4:105–15.PubMedPubMedCentralCrossRefGoogle Scholar
  180. Monaco F, Servo S, Cavanna AE. Famous people with Gilles de la Tourette syndrome? J Psychosom Res. 2009;67(6):485–90.PubMedCrossRefPubMedCentralGoogle Scholar
  181. Monaco F, Mula M, Cavanna AE. The neurophilosophy of epileptic experiences. Acta Neuropsychiatr. 2011;23(4):184–7.PubMedCrossRefGoogle Scholar
  182. Monzani A, Bona G, Moia S, Corrias A, Miglio C, Cavanna AE. Tourette syndrome in a patient with resistance to thyroid hormone syndrome. J Neuropsychiatry Clin Neurosci. 2013;25(4):E09–10.PubMedCrossRefGoogle Scholar
  183. Mula M, Viana M, Jauch R, Schmitz B, Bettucci D, Cavanna AE, Strigaro G, Tota MG, Israel H, Reuter U, Monaco F. Health-related quality of life measures and psychiatric comorbidity in patients with migraine. Eur J Neurol. 2009;16(9):1017–21.PubMedCrossRefGoogle Scholar
  184. Müller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vandewalle V, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry. 2011;20(4):209–17.PubMedCrossRefGoogle Scholar
  185. Nagai Y, Cavanna AE, Critchley HD, Stern JJ, Robertson MM, Joyce EM. Biofeedback treatment for Tourette syndrome: a preliminary randomized controlled trial. Cogn Behav Neurol. 2014;27(1):17–24.PubMedCrossRefGoogle Scholar
  186. Nakum S, Cavanna AE. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson’s disease following dopaminergic therapy: a systematic literature review. Parkinsonism Relat Disord. 2016;25:10–6.CrossRefPubMedGoogle Scholar
  187. Nani A, Cavanna AE. The quantitative measurement of consciousness during epileptic seizures. Epilepsy Behav. 2014;30:2–5.PubMedPubMedCentralCrossRefGoogle Scholar
  188. Neal M, Cavanna AE. “Not just right experiences” in patients with Tourette syndrome: complex motor tics or compulsions? Psychiatry Res. 2013;210(2):559–63.PubMedCrossRefGoogle Scholar
  189. Neal M, Cavanna AE. Selective sound sensitivity syndrome (misophonia) in a patient with Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2013;25(1):E01.PubMedCrossRefGoogle Scholar
  190. Nimmagadda SR, Agrawal N, Worrall-Davies A, Markova I, Rickards H. Determinants of irritability in Huntington’s disease. Acta Neuropsychiatr. 2011;23(6):309–14.PubMedCrossRefGoogle Scholar
  191. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS, PREDICT-HD Investigators Coordinators of Huntington Study Group (HSG). Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010;40(3):544–54.PubMedPubMedCentralCrossRefGoogle Scholar
  192. Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB, Investigators of the European Huntington’s Disease Network. Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. Version 2. PLoS Curr. 2010;2:RRN1184.PubMedCentralCrossRefPubMedGoogle Scholar
  193. Orth M, European Huntington’s Disease Network, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. J Neurol Neurosurg Psychiatry. 2011;82(12):1409–12.PubMedCrossRefGoogle Scholar
  194. Osman A, Seri S, Cavanna AE. Clinical characteristics of patients with epilepsy in a specialist neuropsychiatry service. Epilepsy Behav. 2016;58:44–7.PubMedCrossRefGoogle Scholar
  195. Panunzi S, Cardona F, De Liso P, Brinciotti M, Cavanna AE. Ictal coprolalia in a patient with temporal lobe epilepsy. J Neuropsychiatry Clin Neurosci. 2013;25(4):E48–9.PubMedCrossRefGoogle Scholar
  196. Pidgeon C, Rickards H. The pathophysiology and pharmacological treatment of Huntington disease. Behav Neurol. 2013;26(4):245–53.PubMedPubMedCentralCrossRefGoogle Scholar
  197. Piedad JC, Cavanna AE. Dyskinesias and treatment with pramipexole in patients with Parkinson’s disease. Parkinsons Dis. 2012;2012:473769.PubMedPubMedCentralGoogle Scholar
  198. Piedad JC, Cavanna AE. Depression in Tourette syndrome: a controlled and comparison study. J Neurol Sci. 2016;364:128–32.PubMedCrossRefPubMedCentralGoogle Scholar
  199. Piedad J, Rickards H, Besag FM, Cavanna AE. Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs. 2012;26(4):319–35.PubMedCrossRefGoogle Scholar
  200. Piedad JC, Rickards HE, Cavanna AE. What patients with Gilles de la Tourette syndrome should be treated with deep brain stimulation and what is the best target? Neurosurgery. 2012;71(1):173–92.PubMedPubMedCentralCrossRefGoogle Scholar
  201. Pietracupa S, Bruno E, Cavanna AE, Falla M, Zappia M, Colosimo C. Scales for hyperkinetic disorders: a systematic review. J Neurol Sci. 2015;358(1–2):9–21.PubMedPubMedCentralCrossRefGoogle Scholar
  202. Porta M, Brambilla A, Cavanna AE, Servello D, Sassi M, Rickards H, Robertson MM. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. Neurology. 2009;73(17):1375–80.PubMedCrossRefPubMedCentralGoogle Scholar
  203. Porta M, Sassi M, Ali F, Cavanna AE, Servello D. Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective. J Psychosom Res. 2009b;67(6):585–90.PubMedCrossRefGoogle Scholar
  204. Porta M, Cavanna AE, Zekaj E, D’Adda F, Servello D. Selection of patients with Tourette syndrome for deep brain stimulation surgery. Behav Neurol. 2013;27(1):125–31.PubMedPubMedCentralCrossRefGoogle Scholar
  205. Prontera P, Napolioni V, Ottaviani V, Rogaia D, Fusco C, Augello B, Serino D, Parisi V, Bernardini L, Merla G, Cavanna AE, Donti E. DPP6 gene disruption in a family with Gilles de la Tourette syndrome. Neurogenetics. 2014;15(4):237–42.PubMedCrossRefPubMedCentralGoogle Scholar
  206. Quarrell OW, Handley O, O’Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB, European Huntington’s Disease Network. Discrepancies in reporting the CAG repeat lengths for Huntington’s disease. Eur J Hum Genet. 2012;20(1):20–6.PubMedCrossRefGoogle Scholar
  207. Quinn L, Khalil H, Dawes H, Fritz NE, Kegelmeyer D, Kloos AD, Gillard JW, Busse M, Outcome Measures Subgroup of the European Huntington’s Disease Network. Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease. Phys Ther. 2013;93(7):942–56.PubMedCrossRefPubMedCentralGoogle Scholar
  208. Quinn L, Debono K, Dawes H, Rosser AE, Nemeth AH, Rickards H, Tabrizi SJ, Quarrell O, Trender-Gerhard I, Kelson MJ, Townson J, Busse M, Members of the TRAIN-HD project group. Task-specific training in Huntington disease: a randomized controlled feasibility trial. Phys Ther. 2014;94(11):1555–68.PubMedCrossRefPubMedCentralGoogle Scholar
  209. Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Rosser A, Busse M. A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease. Parkinsonism Relat Disord. 2016;31:46–52.PubMedCrossRefPubMedCentralGoogle Scholar
  210. Radja GK, Cavanna AE. Treatment of VGKC complex antibody-associated limbic encephalitis: a systematic review. J Neuropsychiatry Clin Neurosci. 2013;25(4):264–71.PubMedCrossRefPubMedCentralGoogle Scholar
  211. Rajabally YA, Cavanna AE. Health-related quality of life in chronic inflammatory neuropathies: a systematic review. J Neurol Sci. 2015;348(1-2):18–23.PubMedCrossRefPubMedCentralGoogle Scholar
  212. Rajabally YA, Seri S, Cavanna AE. Neuropsychiatric manifestations in inflammatory neuropathies: a systematic review. Muscle Nerve. 2016;54(1):1–8.PubMedPubMedCentralCrossRefGoogle Scholar
  213. Rajagopal S, Cavanna AE. Premonitory urges and repetitive behaviours in adult patients with Tourette syndrome. Neurol Sci. 2014;35(6):969–71.PubMedCrossRefGoogle Scholar
  214. Rajagopal S, Seri And S, Cavanna AE. Premonitory urges and sensorimotor processing in Tourette syndrome. Behav Neurol. 2013;27(1):65–73.PubMedPubMedCentralCrossRefGoogle Scholar
  215. Reilmann R, Rouzade-Dominguez ML, Saft C, Süssmuth SD, Priller J, Rosser A, Rickards H, Schöls L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B. A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington’s disease. Mov Disord. 2015;30(3):427–31.PubMedCrossRefGoogle Scholar
  216. Richieri R, Blackman G, Musil R, Spatola G, Cavanna AE, Lançon C, Régis J. Positive clinical effects of gamma knife capsulotomy in a patient with deep brain stimulation-refractory Tourette Syndrome and Obsessive Compulsive Disorder. Clin Neurol Neurosurg. 2018;170:34–7.PubMedCrossRefGoogle Scholar
  217. Rickards H. Functional neuroimaging in Tourette syndrome. J Psychosom Res. 2009;67(6):575–84.PubMedCrossRefGoogle Scholar
  218. Rickards H. Tourette’s syndrome and other tic disorders. Pract Neurol. 2010;10(5):252–9.PubMedCrossRefGoogle Scholar
  219. Rickards H. Republished review: Tourette’s syndrome and other tic disorders. Postgrad Med J. 2011;87(1024):142–9.PubMedCrossRefGoogle Scholar
  220. Rickards H, Cavanna AE. Gilles de la Tourette: the man behind the syndrome. J Psychosom Res. 2009;67(6):469–74.PubMedCrossRefGoogle Scholar
  221. Rickards H, Silver J. Don’t know what they are, but treatable? Therapies for conversion disorders. J Neurol Neurosurg Psychiatry. 2014;85(8):830–1.PubMedCrossRefGoogle Scholar
  222. Rickards H, Woolf I, Cavanna AE. “Trousseau’s disease:” a description of the Gilles de la Tourette syndrome 12 years before 1885. Mov Disord. 2010;25(14):2285–9.PubMedCrossRefGoogle Scholar
  223. Rickards H, De Souza J, Crooks J, van Walsem MR, van Duijn E, Landwehrmeyer B, Squitieri F, Simpson SA, European Huntington’s Disease Network. Discriminant analysis of beck depression inventory and Hamilton rating scale for depression in Huntington’s disease. J Neuropsychiatry Clin Neurosci. 2011;23(4):399–402.PubMedCrossRefGoogle Scholar
  224. Rickards H, De Souza J, van Walsem M, van Duijn E, Simpson SA, Squitieri F, Landwehrmeyer B, European Huntington’s Disease Network. Factor analysis of behavioural symptoms in Huntington’s disease. J Neurol Neurosurg Psychiatry. 2011;82(4):411–2.PubMedCrossRefGoogle Scholar
  225. Rickards H, Cavanna AE, Worrall R. Treatment practices in Tourette syndrome: the European perspective. Eur J Paediatr Neurol. 2012;16(4):361–4.PubMedCrossRefGoogle Scholar
  226. Rickards H, Paschou P, Rizzo R, Stern JS. A brief history of the European Society for the Study of Tourette Syndrome. Behav Neurol. 2013;27(1):3–5.PubMedPubMedCentralCrossRefGoogle Scholar
  227. Rizzo R, Eddy CM, Calí P, Gulisano M, Cavanna AE. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome. Pediatr Neurol. 2012;47(6):419–22.PubMedCrossRefGoogle Scholar
  228. Robertson MM, Cavanna AE. The many faces of Gilles de la Tourette syndrome. J Psychosom Res. 2009;67(6):467–8.PubMedCrossRefGoogle Scholar
  229. Robertson MM, Eapen V, Cavanna AE. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res. 2009;67(6):475–83.PubMedPubMedCentralCrossRefGoogle Scholar
  230. Robertson MM, Cavanna AE, Eapen V. Gilles de la Tourette syndrome and disruptive behavior disorders: prevalence, associations, and explanation of the relationships. J Neuropsychiatry Clin Neurosci. 2015;27(1):33–41.PubMedCrossRefPubMedCentralGoogle Scholar
  231. Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011;20(4):173–96.PubMedPubMedCentralCrossRefGoogle Scholar
  232. Roessner V, Rothenberger A, Rickards H, Hoekstra PJ. European clinical guidelines for Tourette syndrome and other tic disorders. Eur Child Adolesc Psychiatry. 2011;20(4):153–4.PubMedPubMedCentralCrossRefGoogle Scholar
  233. Roper LS, Saifee TA, Parees I, Rickards H, Edwards MJ. How to use the entrainment test in the diagnosis of functional tremor. Pract Neurol. 2013;13(6):396–8.PubMedCrossRefPubMedCentralGoogle Scholar
  234. Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D, REGISTRY Investigators of the European Huntington’s Disease Network, Arning L. NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr. 2011;3:RRN1247.PubMedPubMedCentralGoogle Scholar
  235. Shereef H, Cavanna AE. The “brother’s arm:” alien hand syndrome after right posterior parietal lesion. J Neuropsychiatry Clin Neurosci. 2013;25(4):E02.PubMedCrossRefPubMedCentralGoogle Scholar
  236. Silvestri PR, Chiarotti F, Baglioni V, Neri V, Cardona F, Cavanna AE. Health-related quality of life in patients with Gilles de la Tourette syndrome at the transition between adolescence and adulthood. Neurol Sci. 2016;37(11):1857–60.PubMedPubMedCentralCrossRefGoogle Scholar
  237. Silvestri PR, Chiarotti F, Baglioni V, Neri V, Cardona F, Cavanna AE. A preliminary examination of self-concept in older adolescents and young adults with Gilles de la Tourette syndrome. Eur J Paediatr Neurol. 2017;21(3):468–74.PubMedCrossRefPubMedCentralGoogle Scholar
  238. Smith MM, Mills JA, Epping EA, Westervelt HJ, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Neuropsychology. 2012;26(5):664–9.PubMedPubMedCentralCrossRefGoogle Scholar
  239. Spencer AH, Rickards H, Fasano A, Cavanna AE. The prevalence and clinical characteristics of punding in Parkinson’s disease. Mov Disord. 2011;26(4):578–86.CrossRefPubMedGoogle Scholar
  240. Srirathan H, Cavanna AE. Research trends in the neuropsychiatry literature since the new millennium. J Neuropsychiatry Clin Neurosci. 2015;27(4):354–61.CrossRefPubMedPubMedCentralGoogle Scholar
  241. Su MT, McFarlane F, Cavanna AE, Termine C, Murray I, Heidemeyer L, Heyman I, Murphy T. The English version of the Gilles de la Tourette syndrome-quality of life scale for children and adolescents (C&A-GTS-QOL). J Child Neurol. 2017;32(1):76–83.PubMedCrossRefPubMedCentralGoogle Scholar
  242. Tarrant N, Cavanna AE, Rickards H. Pathological gambling associated with modafinil. J Neuropsychiatry Clin Neurosci. 2010;22(1):123.E27–8.CrossRefGoogle Scholar
  243. Termine C, Selvini C, Balottin U, Luoni C, Eddy CM, Cavanna AE. Self-, parent-, and teacher-reported behavioral symptoms in youngsters with Tourette syndrome: a case-control study. Eur J Paediatr Neurol. 2011;15(2):95–100.PubMedCrossRefPubMedCentralGoogle Scholar
  244. Termine C, Luoni C, Selvini C, Bandera V, Balottin U, Eddy CM, Cavanna AE. Mother-child agreement on behavioral ratings in Tourette syndrome: a controlled study. J Child Neurol. 2014;29(1):79–83.PubMedCrossRefGoogle Scholar
  245. Termine C, Luoni C, Fontolan S, Selvini C, Perego L, Pavone F, Rossi G, Balottin U, Cavanna AE. Impact of co-morbid attention-deficit and hyperactivity disorder on cognitive function in male children with Tourette syndrome: a controlled study. Psychiatry Res. 2016;243:263–7.PubMedCrossRefGoogle Scholar
  246. Termine C, Luoni C, Fontolan S, Selvini C, Perego L, Pavone F, Rossi G, Balottin U, Cavanna AE. The multiple phenotypes of Tourette syndrome and attention-deficit hyperactivity disorder. Psychiatry Res. 2017;258:611.PubMedCrossRefGoogle Scholar
  247. Thomas R, Cavanna AE. The pharmacology of Tourette syndrome. J Neural Transm. 2013;120(4):689–94.PubMedCrossRefGoogle Scholar
  248. Valcárcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, García-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H, REGISTRY investigators of the European Huntington’s Disease Network (EHDN), Zubiaga AM, Aguirre A. Does arterial hypertension influence the onset of Huntington’s disease? PLoS One. 2018;13(5):e0197975.PubMedPubMedCentralCrossRefGoogle Scholar
  249. van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB, European Huntington’s Disease Network Behavioural Phenotype Working Group. Neuropsychiatric symptoms in a European Huntington’s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry. 2014;85(12):1411–8.PubMedPubMedCentralCrossRefGoogle Scholar
  250. Vattakatuchery JJ, Rickards H, Cavanna AE. Pathogenic mechanisms of depression in multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2011;23(3):261–76.PubMedCrossRefGoogle Scholar
  251. Verdellen C, van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20(4):197–207.PubMedCrossRefGoogle Scholar
  252. Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ, Registry investigators of the European Huntington’s Disease Network. β-Defensin genomic copy number does not influence the age of onset in Huntington’s Disease. J Huntingtons Dis. 2013;2(1):107–24.PubMedPubMedCentralGoogle Scholar
  253. Voon V, Cavanna AE, Coburn K, Sampson S, Reeve A, WC LF Jr, (On behalf of the American Neuropsychiatric Association Committee for Research). Functional neuroanatomy and neurophysiology of functional neurological disorders (conversion disorder). J Neuropsychiatry Clin Neurosci. 2016;28(3):168–90.PubMedPubMedCentralCrossRefGoogle Scholar
  254. Waldon K, Hill J, Termine C, Balottin U, Cavanna AE. Trials of pharmacological interventions for Tourette syndrome: a systematic review. Behav Neurol. 2013;26(4):265–73.PubMedPubMedCentralCrossRefGoogle Scholar
  255. Ward P, Seri And S, Cavanna AE. Functional neuroanatomy and behavioural correlates of the basal ganglia: evidence from lesion studies. Behav Neurol. 2013;26(4):219–23.PubMedPubMedCentralCrossRefGoogle Scholar
  256. White PD, Rickards H, Zeman AZ. Classifying mental and neurological conditions together: authors’ reply to letters. BMJ. 2012;345:e4906.PubMedCrossRefPubMedCentralGoogle Scholar
  257. White PD, Rickards H, Zeman AZ. Time to end the distinction between mental and neurological illnesses. BMJ. 2012;344:e3454.PubMedPubMedCentralCrossRefGoogle Scholar
  258. Whittington C, Pennant M, Kendall T, Glazebrook C, Trayner P, Groom M, Hedderly T, Heyman I, Jackson G, Jackson S, Murphy T, Rickards H, Robertson M, Stern J, Hollis C. Practitioner review: treatments for Tourette syndrome in children and young people—a systematic review. J Child Psychol Psychiatry. 2016;57(9):988–1004.PubMedPubMedCentralCrossRefGoogle Scholar
  259. Wright A, Rickards H, Cavanna AE. Impulse-control disorders in Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2012;24(1):16–27.PubMedPubMedCentralCrossRefGoogle Scholar
  260. Zeman A, Rickards H, White P. Integrating alienists. Lancet Psychiatry. 2014;1(5):333.PubMedCrossRefPubMedCentralGoogle Scholar

Websites

  1. Official website of the British Neuropsychiatry Association (BNPA): https://bnpa.org.uk/
  2. Official website of the American Neuropsychiatric Association (ANPA): https://anpa.wildapricot.org/
  3. Official website of the International Neuropsychiatric Association (INA): https://www.inawebsite.org/

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Andrea E. Cavanna
    • 1
  1. 1.Dept of NeuropsychiatryUniversity of BirminghamBirminghamUnited Kingdom

Personalised recommendations